`Rigged’ system blocks use of lower-cost drugs, FDA chief says

CVS HEALTH'S pharmacy benefit management business came under fire, along with other PBMs, from the head of the Food and Drug Administration for holding drug prices artificially high. / BLOOMBERG FILE PHOTO/MICHAEL NAGLE
CVS HEALTH'S pharmacy benefit management business came under fire, along with other PBMs, from the head of the Food and Drug Administration for holding drug prices artificially high. / BLOOMBERG FILE PHOTO/MICHAEL NAGLE
WASHINGTON – A “rigged payment scheme” between drug plans, insurers and pharmaceutical companies has blocked access to less-expensive versions of some of the most costly drugs in the United States, the head of the Food and Drug Administration said Wednesday. FDA Commissioner Scott Gottlieb aimed particular criticism at giant pharmacy benefit managers that contract with health plans…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -